Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chadi Nabhan

Showing results (31-40 of 199) with videos related to

Pageof 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Thalidomide and dexamethasone for newly diagnosed multiple myeloma: is this really the standard of care?Chadi Nabhan, Jacob D Bitran
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Chronic lymphocytic leukemia: to transplant or not to transplant... that is the question?Chadi Nabhan, Jacob D Bitran
JAMA|December 3, 2014
Chronic lymphocytic leukemia: a clinical reviewChadi Nabhan, Steven T Rosen
Journal of Oncology Practice|June 16, 2017
Value-Based Calculators in Cancer: Current State and ChallengesChadi Nabhan, Bruce A Feinberg
Seminars in Oncology|February 14, 2002
Conceptual aspects of combining rituximab and Campath-1H in the treatment of chronic lymphocytic leukemiaChadi Nabhan, Steven T Rosen
Hematology/Oncology Clinics of North America|March 12, 2003
Current concepts in the diagnosis and management of thrombotic thrombocytopenic purpuraChadi Nabhan, Hau C Kwaan
JCO Clinical Cancer Informatics|January 19, 2019
Clinical Pathways in Oncology: Software SolutionsChadi Nabhan, Bruce A Feinberg
Journal of General Internal Medicine|July 12, 2019
Strengthening the Medical Error "Meme Pool"Benjamin L Mazer, Chadi Nabhan
The New England Journal of Medicine|October 21, 2005
Erlotinib in lung cancerChadi Nabhan, Jacob D Bitran
Clinical Lymphoma|April 24, 2002
Early phase I/II trials with gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukemiaChadi Nabhan, Martin S Tallman
Pageof 20

Showing results (31-40 of 199) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Thalidomide and dexamethasone for newly diagnosed multiple myeloma: is this really the standard of care?Chadi Nabhan, Jacob D Bitran
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Chronic lymphocytic leukemia: to transplant or not to transplant... that is the question?Chadi Nabhan, Jacob D Bitran
JAMA|December 3, 2014
Chronic lymphocytic leukemia: a clinical reviewChadi Nabhan, Steven T Rosen
Journal of Oncology Practice|June 16, 2017
Value-Based Calculators in Cancer: Current State and ChallengesChadi Nabhan, Bruce A Feinberg
Seminars in Oncology|February 14, 2002
Conceptual aspects of combining rituximab and Campath-1H in the treatment of chronic lymphocytic leukemiaChadi Nabhan, Steven T Rosen
Hematology/Oncology Clinics of North America|March 12, 2003
Current concepts in the diagnosis and management of thrombotic thrombocytopenic purpuraChadi Nabhan, Hau C Kwaan
JCO Clinical Cancer Informatics|January 19, 2019
Clinical Pathways in Oncology: Software SolutionsChadi Nabhan, Bruce A Feinberg
Journal of General Internal Medicine|July 12, 2019
Strengthening the Medical Error "Meme Pool"Benjamin L Mazer, Chadi Nabhan
The New England Journal of Medicine|October 21, 2005
Erlotinib in lung cancerChadi Nabhan, Jacob D Bitran
Clinical Lymphoma|April 24, 2002
Early phase I/II trials with gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukemiaChadi Nabhan, Martin S Tallman
Pageof 20